Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons

Selvan Ravindran, Olga L. Zharikova, Ronald A. Hill, Tatiana Nanovskaya, Gary Hankins, Mahmoud Ahmed

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Glyburide (glibenclamide) is a second-generation sulfonylurea used for treatment of type-2 and gestational diabetes mellitus. To date, two glyburide metabolites have been identified in maternal urine: namely, 4-trans-hydroxycyclohexyl glyburide and 3-cis-hydroxycyclohexyl glyburide. The use of glyburide to treat gestational diabetes prompted us to investigate its metabolism by the placenta. The metabolism of glyburide by microsomal preparations from human and baboon placenta was compared with metabolism by their livers. The metabolites formed by the microsomes of the four tissues were identified by high-performance liquid chromatography-mass spectrometry using retention times, ion current (extracted at m/z 510), and selected-ion monitoring. The data obtained revealed the formation of six distinct hydroxylated derivatives of glyburide by each of the four microsomal preparations. However, the amounts of the six metabolites formed by the placentas were a fraction of that formed by the livers. Moreover, the relative quantities of each metabolite formed differed between species as well as between the two tissues. Also, the structure of the unidentified metabolites was determined by comparison with synthesized standards. These metabolites were identified as the 4-cis-hydroxycyclohexyl glyburide, 3-trans-hydroxycyclohexyl glyburide, and 2-trans-hydroxycyclohexyl glyburide. Therefore, one glyburide metabolite remains to be identified, but the data we obtained allowed us to suggest its structure.

Original languageEnglish (US)
Pages (from-to)1730-1737
Number of pages8
JournalBiochemical Pharmacology
Volume72
Issue number12
DOIs
StatePublished - Dec 15 2006

Fingerprint

Papio
Glyburide
Metabolites
Microsomes
Liver
Metabolism
Placenta
Gestational Diabetes
Medical problems
Ions
Tissue
High performance liquid chromatography
Type 2 Diabetes Mellitus
Mass spectrometry
Mass Spectrometry
High Pressure Liquid Chromatography
Mothers
Urine

Keywords

  • Baboon placenta
  • Gestational diabetes
  • Glyburide
  • Human placenta
  • Mass spectrometry
  • Metabolism
  • Pregnancy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. / Ravindran, Selvan; Zharikova, Olga L.; Hill, Ronald A.; Nanovskaya, Tatiana; Hankins, Gary; Ahmed, Mahmoud.

In: Biochemical Pharmacology, Vol. 72, No. 12, 15.12.2006, p. 1730-1737.

Research output: Contribution to journalArticle

Ravindran, Selvan ; Zharikova, Olga L. ; Hill, Ronald A. ; Nanovskaya, Tatiana ; Hankins, Gary ; Ahmed, Mahmoud. / Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. In: Biochemical Pharmacology. 2006 ; Vol. 72, No. 12. pp. 1730-1737.
@article{56ad08d728a943d5a9f09133af993759,
title = "Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons",
abstract = "Glyburide (glibenclamide) is a second-generation sulfonylurea used for treatment of type-2 and gestational diabetes mellitus. To date, two glyburide metabolites have been identified in maternal urine: namely, 4-trans-hydroxycyclohexyl glyburide and 3-cis-hydroxycyclohexyl glyburide. The use of glyburide to treat gestational diabetes prompted us to investigate its metabolism by the placenta. The metabolism of glyburide by microsomal preparations from human and baboon placenta was compared with metabolism by their livers. The metabolites formed by the microsomes of the four tissues were identified by high-performance liquid chromatography-mass spectrometry using retention times, ion current (extracted at m/z 510), and selected-ion monitoring. The data obtained revealed the formation of six distinct hydroxylated derivatives of glyburide by each of the four microsomal preparations. However, the amounts of the six metabolites formed by the placentas were a fraction of that formed by the livers. Moreover, the relative quantities of each metabolite formed differed between species as well as between the two tissues. Also, the structure of the unidentified metabolites was determined by comparison with synthesized standards. These metabolites were identified as the 4-cis-hydroxycyclohexyl glyburide, 3-trans-hydroxycyclohexyl glyburide, and 2-trans-hydroxycyclohexyl glyburide. Therefore, one glyburide metabolite remains to be identified, but the data we obtained allowed us to suggest its structure.",
keywords = "Baboon placenta, Gestational diabetes, Glyburide, Human placenta, Mass spectrometry, Metabolism, Pregnancy",
author = "Selvan Ravindran and Zharikova, {Olga L.} and Hill, {Ronald A.} and Tatiana Nanovskaya and Gary Hankins and Mahmoud Ahmed",
year = "2006",
month = "12",
day = "15",
doi = "10.1016/j.bcp.2006.08.024",
language = "English (US)",
volume = "72",
pages = "1730--1737",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons

AU - Ravindran, Selvan

AU - Zharikova, Olga L.

AU - Hill, Ronald A.

AU - Nanovskaya, Tatiana

AU - Hankins, Gary

AU - Ahmed, Mahmoud

PY - 2006/12/15

Y1 - 2006/12/15

N2 - Glyburide (glibenclamide) is a second-generation sulfonylurea used for treatment of type-2 and gestational diabetes mellitus. To date, two glyburide metabolites have been identified in maternal urine: namely, 4-trans-hydroxycyclohexyl glyburide and 3-cis-hydroxycyclohexyl glyburide. The use of glyburide to treat gestational diabetes prompted us to investigate its metabolism by the placenta. The metabolism of glyburide by microsomal preparations from human and baboon placenta was compared with metabolism by their livers. The metabolites formed by the microsomes of the four tissues were identified by high-performance liquid chromatography-mass spectrometry using retention times, ion current (extracted at m/z 510), and selected-ion monitoring. The data obtained revealed the formation of six distinct hydroxylated derivatives of glyburide by each of the four microsomal preparations. However, the amounts of the six metabolites formed by the placentas were a fraction of that formed by the livers. Moreover, the relative quantities of each metabolite formed differed between species as well as between the two tissues. Also, the structure of the unidentified metabolites was determined by comparison with synthesized standards. These metabolites were identified as the 4-cis-hydroxycyclohexyl glyburide, 3-trans-hydroxycyclohexyl glyburide, and 2-trans-hydroxycyclohexyl glyburide. Therefore, one glyburide metabolite remains to be identified, but the data we obtained allowed us to suggest its structure.

AB - Glyburide (glibenclamide) is a second-generation sulfonylurea used for treatment of type-2 and gestational diabetes mellitus. To date, two glyburide metabolites have been identified in maternal urine: namely, 4-trans-hydroxycyclohexyl glyburide and 3-cis-hydroxycyclohexyl glyburide. The use of glyburide to treat gestational diabetes prompted us to investigate its metabolism by the placenta. The metabolism of glyburide by microsomal preparations from human and baboon placenta was compared with metabolism by their livers. The metabolites formed by the microsomes of the four tissues were identified by high-performance liquid chromatography-mass spectrometry using retention times, ion current (extracted at m/z 510), and selected-ion monitoring. The data obtained revealed the formation of six distinct hydroxylated derivatives of glyburide by each of the four microsomal preparations. However, the amounts of the six metabolites formed by the placentas were a fraction of that formed by the livers. Moreover, the relative quantities of each metabolite formed differed between species as well as between the two tissues. Also, the structure of the unidentified metabolites was determined by comparison with synthesized standards. These metabolites were identified as the 4-cis-hydroxycyclohexyl glyburide, 3-trans-hydroxycyclohexyl glyburide, and 2-trans-hydroxycyclohexyl glyburide. Therefore, one glyburide metabolite remains to be identified, but the data we obtained allowed us to suggest its structure.

KW - Baboon placenta

KW - Gestational diabetes

KW - Glyburide

KW - Human placenta

KW - Mass spectrometry

KW - Metabolism

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=33751085933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751085933&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2006.08.024

DO - 10.1016/j.bcp.2006.08.024

M3 - Article

VL - 72

SP - 1730

EP - 1737

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 12

ER -